References
- Arlt A, Kruse ML, Breitenbroich M, Gehrz A, Koc B, Minkenberg J, Folsch UR, Schafer H (2003) The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death. Oncogene. 22:3343-3351. https://doi.org/10.1038/sj.onc.1206524
- Bae J, Donigian JR, Hsueh AJ (2003) Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis. J Biol Chem 278:5195-5204. https://doi.org/10.1074/jbc.M201988200
- Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393-403. https://doi.org/10.1016/j.molcel.2004.12.030
- Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G, Porteu F (2002) IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. EMBO J 21:5151-5163. https://doi.org/10.1093/emboj/cdf488
- Hand R, Fremegen A, Chmiel SJ, Recant W, Berk R, Sylvester J, Sener S (1993) Staging procedures, clinical management and survival outcome for ovarian carcinoma. J Am Med Assoc 269:1119-1122. https://doi.org/10.1001/jama.269.9.1119
- Jamil S, Sobouti R, Hojabrpour, Raj M, Kast J, Duronio V (2005) A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem J 387:659-667. https://doi.org/10.1042/BJ20041596
- Kazushi S, Osamu K, Yuko S, Shoji, Keiji M, Nobutaka N, Koso O (2002) Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res 93:542-550. https://doi.org/10.1111/j.1349-7006.2002.tb01289.x
- Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8:1348-1358. https://doi.org/10.1038/ncb1499
- Kondratyev AD, Chung KN, Jung MO (1996) Identification and characterization of a radiation-inducible glycosylated human early-response gene. Cancer Res 56: 1498-1502.
- Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90:3516-3520. https://doi.org/10.1073/pnas.90.8.3516
- Kumar R, Kobayashi T, Warner GM, Wu Y, Salisbury JL, Lingle W, Pittelkow MR (1998) A novel immediate early response gene, IEX-1, is induced by ultraviolet radiation in human keratinocytes. Biochem Biophys Res Commun 253:336-341. https://doi.org/10.1006/bbrc.1998.9692
- Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17:525-535. https://doi.org/10.1016/j.molcel.2005.02.003
- Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, Wang X (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17:1475-1486. https://doi.org/10.1101/gad.1093903
- Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K, Korsmeyer SJ (2005) Obligate role of antiapoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307:1101-1104. https://doi.org/10.1126/science.1106114
- Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406-417. https://doi.org/10.1016/0076-6879(95)60154-6
- Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T (2008) Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451:1116-1120. https://doi.org/10.1038/nature06633
- Schilling D, Pittelkow MR, Kumar R (2001) IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 20:7992-7997. https://doi.org/10.1038/sj.onc.1204965
- Spriggs D (2003) Optimal sequencing in the treatment of recurrent ovarian cancer. Gynecol Oncol 90:S39-43. https://doi.org/10.1016/S0090-8258(03)00471-2
- Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462. https://doi.org/10.1126/science.7878464
- Warr MR, Shore GC (2008) Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 8: 138-147. https://doi.org/10.2174/156652408783769580
- Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF (1998) IEX-1L, an apoptosis inhibitor involved in NF-kappaBmediated cell survival. Science 281:998-1001. https://doi.org/10.1126/science.281.5379.998
- Yoon S, Ha HJ, Kim YH, Won M, Park M, Ko JJ, Lee K, Bae J (2009) IEX-1-induced cell death requires BIM and is modulated by MCL-1. Biochem Biophys Res Commun 382:400-404. https://doi.org/10.1016/j.bbrc.2009.03.037
- Zhang D, Li F, Weidner D, Mnjoyan ZH, Fujise K (2002) Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin. The potential role of MCL1 as a fortilin chaperone. J Biol Chem 277:37430-37438. https://doi.org/10.1074/jbc.M207413200
- Zhang Y, Finegold MJ, Porteu F, Kanteti P, Wu MX (2003) Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene 22:6845-6851. https://doi.org/10.1038/sj.onc.1206707